Breakthrough Busts Ohio Marijuana Monopoly Claims

Warning message

The subscription service is currently unavailable. Please try again later.

Tomorrow at 2pm at the Ohio Statehouse, advocates for medical marijuana research will be announcing their plans to build a $24 million research center in the state of Ohio if Issue 3 should pass in the 2015 election. Speaking at the event will be Dr. Sue Sisley, MD, Principal Investigator for the only FDA-approved randomized controlled trial looking at use of whole-plant marijuana (grown by NIDA) in combat veterans with treatment-resistant post-traumatic stress disorder (PTSD), who will perform her research in Ohio at ICI’s future research facility.

The drive to legalize marijuana in Ohio in 2015, ResponsibleOhio’s Issue 3, has been attacked for its most controversial section, the designation of just ten approved sites for commercial marijuana cultivation. This has led opponents and even the State of Ohio to designate the plan an Ohio marijuana monopoly; though, technically, a market controlled by a small number of wealthy beneficiaries is more properly...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.